Showing posts with label MICHAEL BREEN MD. Show all posts
Showing posts with label MICHAEL BREEN MD. Show all posts

Thursday, July 25, 2013

Dr. Michael Breen: One Stop CRPS CALMARE Treatment and Obstetrics/Gynecological Needs!

Michael Breen M.D. is not licensed to practice medicine in Illinois, though he touts " F-D-A Cleared Non-Invasive Pain Treatment Arrives In Illinois."

The FDA claim is an exagerration, and is a tired one.  CALMARE / CTTC applied to the FDA for permission to market itself as a "TENS" device.

He is, however, licensed as an obstetrician and gynecologist in Texas.  Like Dr. D'Amato of Rhode Island, and Dr. Robert Chalmers, also OB/Gyn specialists. An odd trend.

But it's a refreshing difference from, say Dr. Cooney, a chiropractor.



Returning to the FDA claim:

This is a copy of what Competitive Technologies submitted to the FDA as part of the requirement for 510(k) Premarket Notification.  I think the company's own application answers quite a few questions!

Device Classification Name:  stimulator, nerve, transcutaneous, for pain relief
Regulation Description:  Transcutaneous electrical nerve stimulator for pain relief

510(k) Number: K081255 
Device Name:  SCRAMBLER ST 5 TENS DEVICE
Applicant:  COMPETITIVE TECHNOLOGIES,INC.
49 plain st.
north attleboro, MA 02760 2

Contact:  mary mcnamara
Regulation Number:  882.5890
Classification Product Code:  GZJ 
Date Received:  05/02/2008
Decision Date:  02/20/2009
Decision:  substantially equivalent (SE)
Classification Advisory Committee:  Neurology 
Review Advisory Committee:  Orthopedic 
summary
summary
Type: Traditional 
Reviewed by Third Party:  No 
Expedited Review:  No


From the FDA website:  

Section 510(k) of the Food, Drug and Cosmetic Act requires those device manufacturers who must register to notify FDA their intent to market a medical device. This is known as Premarket Notification (PMN) or 510(k). Under 510(k), before a manufacturer can market a medical device in the United States, they must demonstrate to FDA’s satisfaction that it is substantially equivalent (as safe and effective) to a device already on the market. If FDA rules the device is "substantially equivalent," the manufacturer can market the device. If the device you are researching has been in commercial distribution before 1976 or is substantially equivalent to a device already on the market, you should search FDA’s 510(k) releasable database.
So the irony is that the company claimed and was deemed, in fact, to have "substantial equivalence" to preexisting TENS devices... But now it wants to distance itself from any comparison to TENS technology.  

{snort"}


© 2013 L. Ryan

Wednesday, July 24, 2013

Using suicide to promote CALMARE: SHAME ON YOU!

© 2013 L. Ryan

The utter irresponsibility of this type of marketing leaves me almost speechless.  In a pitch by Michael Breen M.D that references a woman named "Gracie," a "Gracie" that has been recycled, at last count, six times, pushing CALMARE treatment for CRPS / RSD (parent company CTTC -- Competitive Technologies, Inc., a penny stock today hanging at 16 cents on the market) dares to begin by stating:

Gracie Bagosy’s condition is so painful, the highest 

cause of death is suicide.






Of course, I cannot let the subject of CRPS and suicide be brought up blithely, by Breen or by this blog author, so I want to refer readers to the significant time and study invested in the topic by the respected RSDSA, most notably by Linda Lang:


There is a very big difference between living with a chronic disease such as CRPS/RSD and actively dying with a disease such as cancer. Although a literature search reveals claims that CRPS/RSD patients have an extraordinarily high incidence of suicide, and a CRPS/RSD patient actually read testimony into a Subcommittee on Health in June of 2001, saying that CRPS/RSD leads to death and the leading cause of that death is suicide, there is absolutely no evidence to support these statements, in fact there are no statistics at all on CRPS/RSD and suicide. When asked about it in 2001, Dr. Robert Schwartzman said, "…there is no data on RSD and suicide. It clearly happens and is almost always attributed to other causes." He adds that out of 73,500 patients, he has had only three that he is sure did commit suicide. 
Click HERE for a link to RSDSA's extensive look at the statistics and the realities for CRPS and suicidial ideation and action.   I know I think of it every day -- but to use that as a marketing "hook" literally nauseates me, and should you.

FOR PREVIOUS POSTS ON CALMARE/CTTC, CLICK HERE.